Rebecca A Abbott1, Rebecca Whear2, Lauren R Rodgers2, Alison Bethel2, Jo Thompson Coon2, Willem Kuyken3, Ken Stein2, Chris Dickens4. 1. PenCLAHRC, University of Exeter Medical School, Exeter EX2 4SG, United Kingdom. Electronic address: r.a.abbott@exeter.ac.uk. 2. PenCLAHRC, University of Exeter Medical School, Exeter EX2 4SG, United Kingdom. 3. Mood Disorders Centre, College of Life and Environmental Sciences, University of Exeter, EX4 4QG, United Kingdom. 4. Psychology, University of Exeter Medical School, Exeter EX2 4SG, United Kingdom.
Abstract
OBJECTIVE: To determine the effectiveness of mindfulness-based stress reduction (MBSR) and mindfulness-based cognitive therapy (MBCT) on psychological and physical outcomes for people with vascular disease. DESIGN: Systematic review and meta-analysis of randomised controlled trials. DATA SOURCES: AMED, CINAHL, EMBASE, British Nursing Index, Medline, Web of Science, PsycINFO, Cochrane Database of Systematic Reviews, Central, Social Sciences Citation Index, Social Policy and Practice, and HMIC from inception to January 2013. REVIEW METHODS: Articles were screened for inclusion independently by two reviewers. Data extraction and quality appraisal were performed by one reviewer and checked by a second with discrepancies resolved by discussion with a third if necessary. Random-effects meta-analyses were performed. RESULTS: Nine articles (from eight original randomised controlled trials) met eligibility criteria and were included in the final review. In total, 578 participants were enrolled across the trials, with participants presenting with prehypertension/hypertension (n=3 trials), type 1 or 2 diabetes (n=2), heart disease (n=2) and stroke (n=1). Meta-analyses, using standardised mean differences, showed evidence of reductions in stress (-0.36; 95% CI -0.67 to -0.09; p=0.01), depression (-0.35; 95% CI -0.53 to -0.16; p=0.003) and anxiety (-0.50; 95% CI -0.70 to -0.29; p<0.001). Effects on physical outcomes (blood pressure, albuminuria, stress hormones) were mixed. CONCLUSION: Whilst populations with vascular disease appear to derive a range of psychological benefits from MBSR/MBCT intervention, the effects on physical parameters of disease are not yet established. More robust studies, with longer term follow-up, are required to ascertain full effectiveness of such intervention.
OBJECTIVE: To determine the effectiveness of mindfulness-based stress reduction (MBSR) and mindfulness-based cognitive therapy (MBCT) on psychological and physical outcomes for people with vascular disease. DESIGN: Systematic review and meta-analysis of randomised controlled trials. DATA SOURCES: AMED, CINAHL, EMBASE, British Nursing Index, Medline, Web of Science, PsycINFO, Cochrane Database of Systematic Reviews, Central, Social Sciences Citation Index, Social Policy and Practice, and HMIC from inception to January 2013. REVIEW METHODS: Articles were screened for inclusion independently by two reviewers. Data extraction and quality appraisal were performed by one reviewer and checked by a second with discrepancies resolved by discussion with a third if necessary. Random-effects meta-analyses were performed. RESULTS: Nine articles (from eight original randomised controlled trials) met eligibility criteria and were included in the final review. In total, 578 participants were enrolled across the trials, with participants presenting with prehypertension/hypertension (n=3 trials), type 1 or 2 diabetes (n=2), heart disease (n=2) and stroke (n=1). Meta-analyses, using standardised mean differences, showed evidence of reductions in stress (-0.36; 95% CI -0.67 to -0.09; p=0.01), depression (-0.35; 95% CI -0.53 to -0.16; p=0.003) and anxiety (-0.50; 95% CI -0.70 to -0.29; p<0.001). Effects on physical outcomes (blood pressure, albuminuria, stress hormones) were mixed. CONCLUSION: Whilst populations with vascular disease appear to derive a range of psychological benefits from MBSR/MBCT intervention, the effects on physical parameters of disease are not yet established. More robust studies, with longer term follow-up, are required to ascertain full effectiveness of such intervention.
Authors: Laura D Kubzansky; Jeff C Huffman; Julia K Boehm; Rosalba Hernandez; Eric S Kim; Hayami K Koga; Emily H Feig; Donald M Lloyd-Jones; Martin E P Seligman; Darwin R Labarthe Journal: J Am Coll Cardiol Date: 2018-09-18 Impact factor: 24.094
Authors: Elizabeth K Seng; Alexandra B Singer; Christopher Metts; Amy S Grinberg; Zarine S Patel; Maya Marzouk; Lauren Rosenberg; Melissa Day; Mia T Minen; Richard B Lipton; Dawn C Buse Journal: Headache Date: 2019-09-26 Impact factor: 5.887
Authors: Eric B Loucks; Zev Schuman-Olivier; Willoughby B Britton; David M Fresco; Gaelle Desbordes; Judson A Brewer; Carl Fulwiler Journal: Curr Cardiol Rep Date: 2015-12 Impact factor: 2.931
Authors: Elizabeth L Addington; Shireen Javandel; Victor De Gruttola; Robert Paul; Benedetta Milanini; Beau M Ances; Judith T Moskowitz; Victor Valcour Journal: Contemp Clin Trials Date: 2020-09-15 Impact factor: 2.226
Authors: Lori A J Scott-Sheldon; Emily C Gathright; Marissa L Donahue; Brittany Balletto; Melissa M Feulner; Julie DeCosta; Dean G Cruess; Rena R Wing; Michael P Carey; Elena Salmoirago-Blotcher Journal: Ann Behav Med Date: 2020-01-01